Clinical Trial

Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy

Study acronym: fBTsRT
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To determine if fBT+sRT is superior to standard care in terms of urinary toxicity by having fewer patients experience a minimal important decline (MID) in urinary irritation/obstructive QoL
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-09-20; most recent amendment 2025-03-12.
Trial Details
NCT Number NCT04100174
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Prostate Cancer
Enrollment 150 participants
Start Date 2019-07-01
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-13